Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Embecta Corp. - Common Stock (NQ: EMBC )

14.41 +0.59 (+4.27%)
Streaming Delayed Price Updated: 1:54 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Embecta Corp. - Common Stock

< Previous 1 2 3 Next >
Uncovering Potential: Embecta's Earnings Preview
Via Benzinga
UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
From Embecta Corp.
Via GlobeNewswire
embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
From Embecta Corp.
Via GlobeNewswire
embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
Advocacy and professional groups join global diabetes care company at Nasdaq to raise awareness of diabetes, while also commemorating the company’s 100-year legacy of serving this community 
From Embecta Corp.
Via GlobeNewswire
Earnings Preview For Embecta
Via Benzinga
Thursday Is Your Last Chance To Buy Embecta Before The Dividend Payout
Via Benzinga
Embecta: Q4 Earnings Insights
Via Benzinga
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
From Embecta Corp.
Via GlobeNewswire
embecta to Participate in Investor Events
From Embecta Corp.
Via GlobeNewswire
EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024
EMBC stock results show that Embecta beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results
From Embecta Corp.
Via GlobeNewswire
Earnings Preview: Embecta
Via Benzinga
embecta Announces Quarterly Cash Dividend
From Embecta Corp.
Via GlobeNewswire
Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off
Embecta is exploring a potential sale after a nearly 70% drop in share price since its spin-off from Becton Dickinson. The company's U.S. business has struggled with the rise of GLP-1 drugs and... 
Via Benzinga
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
Via Benzinga
embecta to Report Fiscal Third Quarter 2024 Financial Results
From Embecta Corp.
Via GlobeNewswire
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
Via Benzinga
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
From Embecta Corp.
Via GlobeNewswire
Trade Winds Turning: 3 Stocks Poised to Gain from Biden’s China Tariffs
Here are three potential stocks to buy that could benefit from China tariffs amidst the turning trade winds. 
Via InvestorPlace
Topics World Trade
Exposures Tariff
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q2 2024
EMBC stock results show that Embecta beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday
Via Benzinga
US Stocks Mixed; Jobless Claims Rise More Than Expected
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Scheduled For February 9, 2024
Companies Reporting Before The Bell • TELUS (NYSE:TU) is expected to report quarterly earnings at $0.23 per share on revenue of $5.24 billion. 
Via Benzinga
Sustaining Growth Momentum: Dentsply Sirona Continues to Excel and Reports Rising Profits
As the day concludes, Dentsply Sirona (NASDAQ:XRAY) is preparing to distribute a dividend payout of $0.14 per share, resulting in an annualized dividend yield of 1.65%. This payout is exclusive to... 
Via Benzinga
Earnings Scheduled For November 21, 2023
Companies Reporting Before The Bell • Golden Ocean Group (NASDAQ:GOGL) is likely to report quarterly earnings at $0.11 per share on revenue of $149.42 million. 
Via Benzinga
7 Contrarian Stocks to Buy for the High-Stakes Gambler
With limited options available as the market rotates out of risk-on assets, speculators may try their luck with contrarian stocks to buy. 
Via InvestorPlace
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.